The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-Methoxy-2-(3-methoxyanilino)-5H-benzothiopyrano[4,3-d]pyrimidine ID: ALA4244593
PubChem CID: 145984036
Max Phase: Preclinical
Molecular Formula: C19H17N3O2S
Molecular Weight: 351.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(Nc2ncc3c(n2)-c2ccc(OC)cc2SC3)c1
Standard InChI: InChI=1S/C19H17N3O2S/c1-23-14-5-3-4-13(8-14)21-19-20-10-12-11-25-17-9-15(24-2)6-7-16(17)18(12)22-19/h3-10H,11H2,1-2H3,(H,20,21,22)
Standard InChI Key: FUBNUBRUBXFJBO-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.8051 -21.1272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8040 -21.9468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5120 -22.3557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5102 -20.7184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2188 -21.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2177 -21.9443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9239 -22.3533 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.6357 -21.9463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9262 -20.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6359 -21.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3480 -20.7199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3516 -19.8980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6372 -19.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9280 -19.8944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6374 -18.6678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3452 -18.2594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0511 -18.6723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7584 -18.2646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7591 -17.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0466 -17.0379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3421 -17.4479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0959 -22.3548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3885 -21.9457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4658 -18.6738 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4652 -19.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 9 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 22 1 0
22 23 1 0
18 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.43Molecular Weight (Monoisotopic): 351.1041AlogP: 4.51#Rotatable Bonds: 4Polar Surface Area: 56.27Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.85CX Basic pKa: 1.70CX LogP: 4.16CX LogD: 4.16Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -1.19
References 1. Salerno S, García-Argáez AN, Barresi E, Taliani S, Simorini F, La Motta C, Amendola G, Tomassi S, Cosconati S, Novellino E, Da Settimo F, Marini AM, Via LD.. (2018) New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors., 150 [PMID:29547832 ] [10.1016/j.ejmech.2018.03.013 ]